A 'real-world' analysis of risk factors for post liver transplant delirium and the effect on length of stay.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
3
1
2020
medline:
29
7
2021
entrez:
3
1
2020
Statut:
ppublish
Résumé
The development of delirium has been previously demonstrated to be associated with an increased risk of mortality and length of stay post liver transplant (LTx) with multiple risk factors being identified in previous studies. In this study, we have aimed to identify the most important variables associated with the onset of post-LTx delirium and understand the effect on length of stay (LOS). All liver transplants for chronic liver disease between 1 August 2012 and 1 August 2017 were included (n = 793). Data were collected for analysis retrospectively from electronic patient records. Delirium is associated with an overall increased hospital and ICU LOS but not one-year mortality. The risk of developing post-LTx delirium was the greatest among patients: with post-LTx sepsis, who required renal sparing immunosuppression, who received donation after cardiac death (DCD) grafts and who were older. Patients with autoimmune hepatitis, primary biliary cholangitis or primary sclerosing cholangitis seemed to be at lower risk of post-LTx delirium. However, global patient LOS was only prolonged in patients with sepsis and renal failure. Many of the risk factors previously described to be associated with the development of post-LTx delirium were not demonstrated to be significant in this study. Sepsis, renal failure, older age and DCD use are associated with delirium post-LTx. It is unclear if this syndrome is an independent risk factor for increased LOS or if it is a symptom of well established syndromes associated with increased LOS. The role for prophylactic strategies to reduce the incidence of post-LTx delirium is therefore unclear.
Sections du résumé
BACKGROUND
The development of delirium has been previously demonstrated to be associated with an increased risk of mortality and length of stay post liver transplant (LTx) with multiple risk factors being identified in previous studies. In this study, we have aimed to identify the most important variables associated with the onset of post-LTx delirium and understand the effect on length of stay (LOS).
METHODS
All liver transplants for chronic liver disease between 1 August 2012 and 1 August 2017 were included (n = 793). Data were collected for analysis retrospectively from electronic patient records.
RESULTS
Delirium is associated with an overall increased hospital and ICU LOS but not one-year mortality. The risk of developing post-LTx delirium was the greatest among patients: with post-LTx sepsis, who required renal sparing immunosuppression, who received donation after cardiac death (DCD) grafts and who were older. Patients with autoimmune hepatitis, primary biliary cholangitis or primary sclerosing cholangitis seemed to be at lower risk of post-LTx delirium. However, global patient LOS was only prolonged in patients with sepsis and renal failure.
CONCLUSION
Many of the risk factors previously described to be associated with the development of post-LTx delirium were not demonstrated to be significant in this study. Sepsis, renal failure, older age and DCD use are associated with delirium post-LTx. It is unclear if this syndrome is an independent risk factor for increased LOS or if it is a symptom of well established syndromes associated with increased LOS. The role for prophylactic strategies to reduce the incidence of post-LTx delirium is therefore unclear.
Identifiants
pubmed: 31895912
doi: 10.1097/MEG.0000000000001661
pii: 00042737-202010000-00016
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1373-1380Commentaires et corrections
Type : CommentIn
Références
Lescot T, Karvellas CJ, Chaudhury P, Tchervenkov J, Paraskevas S, Barkun J, et al. Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients. Can J Gastroenterol. 2013; 27:207–212
Wang SH, Wang JY, Lin PY, Lin KH, Ko CJ, Hsieh CE, et al. Predisposing risk factors for delirium in living donor liver transplantation patients in intensive care units. Plos One. 2014; 9:e96676
Wu SY, Chen TW, Feng AC, Fan HL, Hsieh CB, Chung KP. Comprehensive risk assessment for early neurologic complications after liver transplantation. World J Gastroenterol. 2016; 22:5548–5557
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:801–810
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990; 113:941–948
Tovikkai C, Charman SC, Praseedom RK, Gimson AE, van der Meulen J. Time spent in hospital after liver transplantation: effects of primary disease and comorbidity. World J Transplant. 2016; 6:742–750
NHS Blood and Transplant. Annual report on liver transplantation – 2017/2018. NHS Blood and Transplant. 2018. Accessed online 08/05/2017. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/12250/nhsbt-liver-transplantation-annual-report-2017-2018.pdf. [Accessed 8 May 2017]
Oliver N, Bohorquez H, Anders S, Freeman A, Fine K, Ahmed E, et al. Post-liver transplant delirium increases mortality and length of stay. Ochsner J. 2017; 17:25–30
Haugen CE, Mountford A, Warsame F, Berkowitz R, Bae S, Thomas AG, et al. Incidence, risk factors, and sequelae of post-kidney transplant delirium. J Am Soc Nephrol. 2018; 29:1752–1759
Wang CG, Qin YF, Wan X, Song LC, Li ZJ, Li H. Incidence and risk factors of postoperative delirium in the elderly patients with hip fracture. J Orthop Surg Res. 2018; 13:186
Feinkohl I, Winterer G, Pischon T. Diabetes is associated with risk of postoperative cognitive dysfunction: a meta-analysis. Diabetes Metab Res Rev. 2017; 33:e2884
Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018; 67:123–133
Bertot LC, Jeffrey GP, Wallace M, MacQuillan G, Garas G, Ching HL, Adams LA. Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma. Hepatol Commun. 2017; 1:53–60
Inouye SK. Delirium in older persons. N Engl J Med. 2006; 354:1157–1165
Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al.; GBD 2016 Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018; 392:1015–1035
Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018; 68:335–352
NHS Blood and Transplantation. Liver Transplantation: Selection criteria and recipient registration. NHS Blood and Transplantation. 2017. http://odt.nhs.uk/pdf/liver_selection_policy.pdf. [Accessed 8 May 2019]
Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014; 60:210–223
Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology. 1998; 28:638–645
Hackworth WA, Heuman DM, Sanyal AJ, Fisher RA, Sterling RK, Luketic VA, et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int. 2009; 29:1071–1077
Leise M, Cárdenas A. Hyponatremia in cirrhosis: implications for liver transplantation. Liver Transpl. 2018; 24:1612–1621
Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, et al. Agitation, delirium, and cognitive outcomes in intracerebral hemorrhage. Psychosomatics. 2017; 58:19–27
Inouye SK, Zhang Y, Jones RN, Kiely DK, Yang F, Marcantonio ER. Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med. 2007; 167:1406–1413
Lee H, Oh SY, Yu JH, Kim J, Yoon S, Ryu HG. Risk factors of postoperative delirium in the intensive care unit after liver transplantation. World J Surg. 2018; 42:2992–2999
Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol. 2019; 70:745–758
Keswani RN, Ahmed A, Keeffe EB. Older age and liver transplantation: a review. Liver Transpl. 2004; 10:957–967
Ebadi M, Montano-Loza AJ. Sarcopenia and frailty in the prognosis of patients on the liver transplant waiting list. Liver Transpl. 2019; 25:7–9
Dolgin NH, Martins PN, Movahedi B, Lapane KL, Anderson FA, Bozorgzadeh A. Functional status predicts postoperative mortality after liver transplantation. Clin Transplant. 2016; 30:1403–1410
Hipp DM, Ely EW. Pharmacological and nonpharmacological management of delirium in critically ill patients. Neurotherapeutics. 2012; 9:158–175
Kork F, Rimek A, Andert A, Becker NJ, Heidenhain C, Neumann UP, et al. Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study. BMC Anesthesiol. 2018; 18:29
Le Dinh H, de Roover A, Kaba A, Lauwick S, Joris J, Delwaide J, et al. Donation after cardio-circulatory death liver transplantation. World J Gastroenterol. 2012; 18:4491–4506
Leithead JA, Armstrong MJ, Corbett C, Andrew M, Kothari C, Gunson BK, et al. Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation. Transpl Int. 2013; 26:1116–1125
Pitarch Martínez M, Sánchez Pérez B, León Díaz FJ, Fernández Aguilar JL, Pérez Daga JA, Montiel Casado MC, et al. Donation after cardiac death in liver transplantation: an additional source of organs with similar results to donation after brain death. Transplant Proc. 2019; 51:4–8
Barreto AG, Daher EF, Silva Junior GB, Garcia JH, Magalhães CB, Lima JM, et al. Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol. 2015; 14:688–694
Anghel D, Tanasescu R, Campeanu A, Lupescu I, Podda G, Bajenaru O. Neurotoxicity of immunosuppressive therapies in organ transplantation. Maedica (Buchar). 2013; 8:170–175
Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, et al. The global burden of sepsis: barriers and potential solutions. Crit Care. 2018; 22:232
Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. J Intensive Care. 2016; 4:18
Wang Y, Gu Y, Huang F, Liu D, Zhang Z, Zhou N, et al. Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation. Mediators Inflamm. 2018; 2018:8703172
Vandecasteele E, De Waele J, Vandijck D, Blot S, Vogelaers D, Rogiers X, et al. Antimicrobial prophylaxis in liver transplant patients–a multicenter survey endorsed by the European liver and intestine transplant association. Transpl Int. 2010; 23:182–190
Berry PS, Rosenberger LH, Guidry CA, Agarwal A, Pelletier S, Sawyer RG. Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial. Liver Transpl. 2019; 25:1043–1053
Zhang H, Lu Y, Liu M, Zou Z, Wang L, Xu FY, et al. Strategies for prevention of postoperative delirium: a systematic review. Critical Care. 2013; 17:R47
Choi JY, Kim JM, Kwon CH, Joh JW, Lee S, Park JB, et al. Use of dexmedetomidine in liver transplant recipients with postoperative agitated delirium. Transplant Proc. 2016; 48:1063–1066